So, binimetinib is this MEK inhibitor that’s mostly used with encorafenib to treat BRAF V600E/K-mutant melanoma. It’s blocking that MEK signaling, which is kind of a big deal in the MAPK/ERK signaling pathway. You can get binimetinib in 15 mg tablets.
The usual dose is 45 mg, taken twice a day. Each pack’s got 84 tablets, so it’s enough for your treatment schedule. The tablets are supposed to be taken on an empty stomach, like an hour before or two hours after eating.
Patients should be monitored closely for potential side effects and adherence to the prescribed regimen, as If you don’t handle these MEK inhibitors right, they can cause some serious trouble.
Reviews
There are no reviews yet.